Trust Homepage > Pathology Homepage

Test and Tubes Database
ID:1010 Tobramycin
Search Links: General Info : Protocols : Patient Info

Description An aminoglycoside that requires therapeutic drug monitoring because of its nephrotoxicity and vestibulo-ototoxicity. Similar to gentamicin multiple daily dosing and once daily dosing regimens exist with various reference ranges. If you are not able to interpret the tobramycin level result safely please contact the microbiology department for clinical advice.
Indication
Additional Info Samples processed by the Department of Blood Sciences (Biochemistry) as of 17.6.11(not microbiology) Please note: test can only be added to samples within 8 hours of collection
Concurrent Testsna
Dietary Requirementsna

Interpretation Advice on interpretation can be found via the microbiology section of the Pathology website: http://www.pathology.leedsth.nhs.uk/pathology/Departments/Microbiology/MicroAntibioticMonitoringGuidelines.aspx

Ref. Range (Male) See notes
Ref. Range (Female)See notes
Ref. Range (Paed)See notes
Ref. Range Notes Adult Ref. Range: Refer to specialist unit protocol eg Cystic fibrosis, Oncology Multi dose: Pre dose <2mg/L Post dose 5-10mg/L (1hour) Paediatric Ref. Range: Refer to specialist unit protocol eg Cystic fibrosis, Oncology Multi dose: Pre dose <2mg/L Post dose 5-10 mg/L (1hour) For more information see Antimicrobial monitoring http://www.pathology.leedsth.nhs.uk/pathology/Departments/Microbiology/MicroAntibioticMonitoringGuidelines.aspx
Unitsmg/L

Other Help:National Laboratory Medicine Handbook

IP Acute TATRefer to Website
IP Routine TATRefer to Website
GP Acute TATRefer to Website
GP Routine TATRefer to Website
Turnround CommentNA
Originally edited by : D Bennett. Last edited on 31/05/2018 09:34:10. Published By Sylvia Bennett on 31/05/2017 09:34:10.